RestorGenex Corporation (OTCQB: RESX), a specialty biopharmaceutical
company initially focused on developing products for dermatology,
ophthalmology and women’s health, announced today the appointment of
Mark Weinberg MD, MBA as Senior Vice President of Clinical Development.
for RestorGenex Appoints Mark Weinberg, MD, MBA Senior Vice President of Clinical Development investment picks